Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are Associated with Susceptibility and Chemotherapy Response in Non-small-cell Lung Cancer Patients

By Li WeiYing   Yue WenTao   Zhang LiNa   Zhao XiaoTing   Ma Li   Yang XueHui   Zhang ChunYan   Wang Yue   Gu Meng  

Lung, Vol. 190, Iss. 1, 2012-02 ,pp. : 91-98

Springer Publishing Company

Access to resources Recommend Favorite

MspA1 polymorphism of the CYP17 gene in breast cysts

By Cristina Tote Franco Pinotti Solange   da Silva Ismael Dale Cotrim Guerreiro   Carvalho Cristina Valeta   Nazário Afonso Celso Pinto  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 443-446

Informa Healthcare

Access to resources Recommend Favorite

Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer

By Suzuki Shioto   Muroishi Youko   Nakanishi Isao   Oda Yoshio  

Journal of Gastroenterology, Vol. 39, Iss. 3, 2004-03 ,pp. : 220-230

Springer Publishing Company

Access to resources Recommend Favorite

Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5′-UTR in patients with polycystic ovarian syndrome

By Marszalek B.   Laciński M.   Babych N.   Capla E.   Biernacka-Lukanty J.   Warenik-Szymankiewicz A.   Trzeciak W. H.  

Gynecological Endocrinology, Vol. 15, Iss. 2, 2001-04 ,pp. : 123-128

Informa Healthcare

Access to resources Recommend Favorite

A new compound heterozygous mutation in the CYP17A1 gene in a female with 17α-hydroxylase/17,20-lyase deficiency

By Lee Eun Sil  

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 720-723

Informa Healthcare

Access to resources Recommend Favorite